Mahmoudi Nima, Renne Julius, Konen Franz Felix, Jendretzky Konstantin Fritz, Möhn Nora, Grote-Levi Lea, Gingele Stefan, Hümmert Martin W, Schwenkenbecher Philipp, Soldatov Alexander, Sühs Kurt-Wolfram, Skripuletz Thomas, Wattjes Mike P
Department of Diagnostic and Interventional Neuroradiology, Hannover Medical School, Hannover, Germany.
Department of Neuroradiology, Charité Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, Charitéplatz 1, 10117, Berlin, Germany.
J Neurol. 2025 Apr 24;272(5):358. doi: 10.1007/s00415-025-13036-w.
Optic neuritis is a frequent initial presentation of multiple sclerosis (MS). It has been suggested that optic nerve lesions on magnetic resonance imaging (MRI) should be considered as an additional lesion location for the demonstration of dissemination in space (DIS) in diagnostic criteria for MS. However, the potential value of optic nerve lesion(s) in MS diagnostic criteria has not yet been sufficiently investigated.
We prospectively included 79 patients presenting with the first clinical event suggestive of MS. All patients underwent neurological work-up, visual-evoked potential (VEP) testing, cerebrospinal fluid (CSF) analysis and contrast-enhanced MRI of the brain, spinal cord and optic nerves (ON). Patients were classified results according to the McDonald 2017 criteria, the MAGNIMS criteria and alternative criteria considering ON imaging findings for both DIS and dissemination in time (DIT).
69 patients (87%) fulfilled DIS according to the MAGNIMS criteria, 67 patients (85%) according to McDonald 2017 and 70 patients (89%) according to the alternative diagnostic criteria. Including contrast enhancing ON lesions as an additional criterion for DIT and disregarding CSF results led to n = 9 (11%) additional patients fulfilling DIT and receiving the diagnosis MS compared to the McDonald 2017 and MAGNIMS criteria. Considering CSF findings in addition to MRI, 68 patients received the diagnosis of MS according to McDonald 2017 compared to 66 patients according to MAGNIMS and 69 patients according to the alternative criteria. Regarding VEP findings as an objective finding of optic nerve involvement, 67 patients had DIS according to MAGNIMS criteria and 71 patients had DIS according to alternative criteria.
Diagnostic criteria including ON lesion on MRI lead only to a slightly higher sensitivity but lower specificity regarding the diagnosis of MS.
视神经炎是多发性硬化症(MS)常见的首发症状。有人提出,在MS的诊断标准中,磁共振成像(MRI)上的视神经病变应被视为空间扩散(DIS)的额外病变部位。然而,视神经病变在MS诊断标准中的潜在价值尚未得到充分研究。
我们前瞻性纳入了79例出现提示MS的首次临床事件的患者。所有患者均接受了神经科检查、视觉诱发电位(VEP)测试、脑脊液(CSF)分析以及脑部、脊髓和视神经(ON)的对比增强MRI检查。根据2017年麦克唐纳标准、MAGNIMS标准以及考虑ON影像学表现的DIS和时间扩散(DIT)的替代标准对患者进行分类。
根据MAGNIMS标准,69例患者(87%)满足DIS;根据2017年麦克唐纳标准,67例患者(85%)满足;根据替代诊断标准,70例患者(89%)满足。与2017年麦克唐纳标准和MAGNIMS标准相比,将对比增强的ON病变作为DIT的额外标准并忽略CSF结果,导致另外9例患者(11%)满足DIT并被诊断为MS。除MRI外考虑CSF结果,根据2017年麦克唐纳标准,68例患者被诊断为MS;根据MAGNIMS标准,66例患者被诊断为MS;根据替代标准,69例患者被诊断为MS。将VEP结果视为视神经受累的客观表现,根据MAGNIMS标准,67例患者有DIS;根据替代标准,71例患者有DIS。
包括MRI上ON病变的诊断标准在MS诊断方面仅导致稍高的敏感性,但特异性较低。